{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:00:44Z","timestamp":1792404044073,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California San Francisco","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jchromb.2015.02.011","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T02:50:10Z","timestamp":1424141410000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Development and validation of a liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\/MS) assay to quantify serum voriconazole"],"prefix":"10.1016","volume":"986-987","author":[{"given":"Justin","family":"Mak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk K.","family":"Sujishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2015.02.011_bib0135","unstructured":"VFEND\u00ae [package insert], Pfizer Inc., New York, NY, 2014."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0140","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0145","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1128\/AAC.50.4.1570-1572.2006","article-title":"Voriconazole therapeutic drug monitoring","volume":"50","author":"Smith","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2125.2003.01994.x","article-title":"Effect of food on the pharmacokinetics of multiple-dose oral voriconazole","volume":"56","author":"Purkins","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0155","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/367933","article-title":"Voriconazole: a new triazole antifungal agent","volume":"36","author":"Johnson","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1179\/1973947812Y.0000000051","article-title":"Voriconazole in clinical practice","volume":"24","author":"Mikulska","year":"2012","journal-title":"J. Chemother."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0165","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1365-2125.2009.03534.x","article-title":"Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype","volume":"68","author":"Scholz","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jchromb.2012.01.015","article-title":"Simultaneous determination of the azoles voriconazole, posaconazole, isavuconazole, itraconazole and its metabolite hydroxyl-itraconazole in human plasma by reversed phase ultra-performance liquid chromatography with ultraviolet detection","volume":"887\u2013888","author":"Verweij-van Wissen","year":"2012","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0175","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jpba.2009.06.030","article-title":"Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection","volume":"50","author":"Gordien","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clinbiochem.2011.11.004","article-title":"Rapid simultaneous determination of voriconazole and its N-oxide in human plasma using an isocratic high-performance liquid chromatography method and its clinical application","volume":"45","author":"Yamada","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0185","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dks285","article-title":"Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC\u2013MS","volume":"67","author":"Baietto","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jchromb.2004.10.069","article-title":"Fast, fully automated analysis of voriconazole from serum by LC\u2013LC\u2013ESI\u2013MS\u2013MS with parallel column-switching technique","volume":"814","author":"Egle","year":"2005","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jchromb.2009.11.017","article-title":"Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC\/MS\/MS","volume":"878","author":"Alffenaar","year":"2010","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0200","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cca.2012.01.008","article-title":"Fast and simple LC\u2013MS\/MS method for quantifying plasma voriconazole","volume":"413","author":"Pauwels","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2015.02.011_bib0205","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00007691-200412000-00011","article-title":"Validation of an assay for voriconazole in serum samples using liquid chromatography\u2013tandem mass spectrometry","volume":"26","author":"Keevil","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00216-012-6176-3","article-title":"An automated method for the simultaneous measurement of azole antifungal drugs in human plasma or serum using turbulent flow liquid chromatography\u2013tandem mass spectrometry","volume":"404","author":"Couchman","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0215","first-page":"730","article-title":"Quantification of voriconazole in plasma by liquid chromatography\u2013tandem mass spectrometry","volume":"43","author":"Vogeser","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0220","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1515\/CCLM.2010.252","article-title":"Liquid chromatography\u2013tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma","volume":"48","author":"Verdier","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cca.2011.09.042","article-title":"Rapid HPLC\u2013MS\/MS method for simultaneous quantitation of four routinely administered triazole antifungals in human plasma","volume":"413","author":"Beste","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2015.02.011_bib0230","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1271\/bbb.100474","article-title":"Fast and reliable determination of voriconazole in human plasma by LC\u2013APCI\u2013MS\/MS","volume":"74","author":"Xiong","year":"2010","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"2","key":"10.1016\/j.jchromb.2015.02.011_bib0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1515\/cclm-2012-0364","volume":"51","author":"Xiong","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/chromsci\/bms178","article-title":"Determination of voriconazole in human plasma by HPLC\u2013ESI\u2013MS and application to pharmacokinetic study","volume":"51","author":"Lin","year":"2013","journal-title":"J. Chromatogr. Sci."},{"issue":"2","key":"10.1016\/j.jchromb.2015.02.011_bib0245","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/bmc.3257","article-title":"UPLC\u2013MS\/MS determination of voriconazole in human plasma and its application to a pharmacokinetic study","volume":"29","author":"Wang","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0250","series-title":"Liquid Chromatography\u2013Mass Spectrometry Methods; Approved Guideline","author":"CLSI","year":"2014"},{"key":"10.1016\/j.jchromb.2015.02.011_bib0255","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2015.02.011_bib0260","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/rcm.6121","article-title":"Comparison between a high-resolution single-stage Orbitrap and a triple quadrupole mass spectrometer for quantitative analyses of drugs","volume":"26","author":"Henry","year":"2012","journal-title":"Rapid Commun. Mass Spectrom."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023215000963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023215000963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T01:26:34Z","timestamp":1537838794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023215000963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":26,"alternative-id":["S1570023215000963"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.02.011","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\/MS) assay to quantify serum voriconazole","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}